Hartung HP - Search Results

1

Development of oral cladribine for the treatment of multiple sclerosis.

Hartung HP, Aktas O, Kieseier B, Giancarlo Comi GC. Hartung HP, et al. J Neurol. 2010 Feb;257(2):163-70. doi: 10.1007/s00415-009-5359-0. J Neurol. 2010. PMID: 19921304 Review.

2

Immune-mediated neuropathies.

Kiefer R, Kieseier BC, Hartung HP. Kiefer R, et al. Among authors: hartung hp. Adv Neurol. 2002;88:111-31. Adv Neurol. 2002. PMID: 11908221 Review. No abstract available.

3

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Brain. 2002 Apr;125(Pt 4):823-34. doi: 10.1093/brain/awf070. Brain. 2002. PMID: 11912115

4

Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome.

Hartung HP, Willison HJ, Kieseier BC. Hartung HP, et al. Curr Opin Neurol. 2002 Oct;15(5):571-7. doi: 10.1097/00019052-200210000-00008. Curr Opin Neurol. 2002. PMID: 12352001 Review. No abstract available.

5

Immune mechanisms in chronic inflammatory demyelinating neuropathy.

Kieseier BC, Dalakas MC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Neurology. 2002 Dec 24;59(12 Suppl 6):S7-12. doi: 10.1212/wnl.59.12_suppl_6.s7. Neurology. 2002. PMID: 12499465 Review.

6

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.

Hartung HP, Gonsette R, König N, Kwiecinski H, Guseo A, Morrissey SP, Krapf H, Zwingers T; Mitoxantrone in Multiple Sclerosis Study Group (MIMS). Hartung HP, et al. Lancet. 2002 Dec 21-28;360(9350):2018-25. doi: 10.1016/S0140-6736(02)12023-X. Lancet. 2002. PMID: 12504397 Clinical Trial.

7

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.

Neuhaus O, Archelos JJ, Hartung HP. Neuhaus O, et al. Among authors: hartung hp. Trends Pharmacol Sci. 2003 Mar;24(3):131-8. doi: 10.1016/S0165-6147(03)00028-2. Trends Pharmacol Sci. 2003. PMID: 12628358 Review.

8

CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.

Kastenbauer S, Koedel U, Wick M, Kieseier BC, Hartung HP, Pfister HW. Kastenbauer S, et al. Among authors: hartung hp. J Neuroimmunol. 2003 Apr;137(1-2):210-7. doi: 10.1016/s0165-5728(03)00085-7. J Neuroimmunol. 2003. PMID: 12667665

9

New immunopathologic insights into multiple sclerosis.

Hemmer B, Kieseier B, Cepok S, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. doi: 10.1007/s11910-003-0085-y. Curr Neurol Neurosci Rep. 2003. PMID: 12691630 Free PMC article. Review.

10

ADAM-10 and ADAM-17 in the inflamed human CNS.

Kieseier BC, Pischel H, Neuen-Jacob E, Tourtellotte WW, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Glia. 2003 Jun;42(4):398-405. doi: 10.1002/glia.10226. Glia. 2003. PMID: 12730960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,122 results

Search Page